Table of Contents Author Guidelines Submit a Manuscript
Case Reports in Anesthesiology
Volume 2013, Article ID 852143, 3 pages
http://dx.doi.org/10.1155/2013/852143
Case Report

Mobitz Type II Atrioventricular Block Followed by Remifentanil in a Patient with Severe Aortic Stenosis

Anesthesia Department, Imam-Reza Hospital, School of Medicine, Mashhad University of Medical Sciences, Mashhad, Iran

Received 23 January 2013; Accepted 18 February 2013

Academic Editors: U. Buyukkocak, M. R. Chakravarthy, and J. Malek

Copyright © 2013 Mehryar Taghavi Gilani and Majid Razavi. This is an open access article distributed under the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.

Linked References

  1. T. D. Egan, “The clinical pharmacology of remifentanil: a brief review,” Journal of Anesthesia, vol. 12, no. 4, pp. 195–204, 1998. View at Publisher · View at Google Scholar · View at Scopus
  2. C. L. Westmoreland, J. F. Hoke, P. S. Sebel, C. C. Hug Jr., and K. T. Muir, “Pharmacokinetics of remifentanil (GI87084B) and its major metabolite (GI90291) in patients undergoing elective inpatient surgery,” Anesthesiology, vol. 79, no. 5, pp. 893–903, 1993. View at Google Scholar · View at Scopus
  3. A. Duman, G. Sarkilar, M. Dayioglu, M. Özden, and N. Görmüs, “Use of remifentanil in a patient with eisenmenger syndrome requiring urgent cesarean section,” Middle East Journal of Anesthesiology, vol. 20, no. 4, pp. 577–580, 2010. View at Google Scholar · View at Scopus
  4. R. Sinha and R. Garg, “Anesthetic management for laparoscopy surgery in a patient with residual coarctation of aorta and mild aortic stenosis,” Journal of Anaesthesiology, Clinical Pharmacology, vol. 27, no. 3, pp. 412–413, 2011. View at Google Scholar
  5. T. T. Lao, M. Sermer, L. MaGee, D. Farine, and J. M. Colman, “Congenital aortic stenosis and pregnancy—a reappraisal,” American Journal of Obstetrics and Gynecology, vol. 169, no. 3, pp. 540–545, 1993. View at Google Scholar · View at Scopus
  6. A. M. Ioscovich, E. Goldszmidt, A. V. Fadeev, S. Grisaru-Granovsky, and S. H. Halpern, “Peripartum anesthetic management of patients with aortic valve stenosis: a retrospective study and literature review,” International Journal of Obstetric Anesthesia, vol. 18, no. 4, pp. 379–386, 2009. View at Publisher · View at Google Scholar · View at Scopus
  7. C. F. Minto, T. W. Schnider, and S. L. Shafer, “Pharmacokinetics and pharmacodynamics of remifentanil II. Model application,” Anesthesiology, vol. 86, no. 1, pp. 24–33, 1997. View at Google Scholar · View at Scopus
  8. C. F. Minto, T. W. Schnider, T. D. Egan et al., “Influence of age and gender on the pharmacokinetics and pharmacodynamics of remifentanil I. Model development,” Anesthesiology, vol. 86, no. 1, pp. 10–23, 1997. View at Publisher · View at Google Scholar · View at Scopus
  9. C. P. McCarroll, L. D. Paxton, P. Elliott, and D. B. Wilson, “Use of remifentanil in a patient with peripartum cardiomyopathy requiring Caesarean section,” British Journal of Anaesthesia, vol. 86, no. 1, pp. 135–138, 2001. View at Publisher · View at Google Scholar · View at Scopus
  10. F. Fattorini, R. Romano, A. Ciccaglioni et al., “Effects of remifentanil on human heart electrical system: a transesophageal pacing electrophysiological study,” Minerva Anestesiologica, vol. 69, no. 9, pp. 673–679, 2003. View at Google Scholar · View at Scopus
  11. K. Maruyama, Y. Nishikawa, H. Nakagawa, J. Ariyama, A. Kitamura, and M. Hayashida, “Can intravenous atropine prevent bradycardia and hypotension during induction of total intravenous anesthesia with propofol and remifentanil,” Journal of Anesthesia, vol. 24, no. 2, pp. 293–296, 2010. View at Publisher · View at Google Scholar · View at Scopus
  12. J. C. Hemming and S. T. Thomas, “Management of patients with valvular heart disease,” in International Pracice of Anesthesia, C. Prys-Roberts and B. R. Thmas Brown, Eds., pp. 3–6, Butterworth Heinemann, Oxford, UK, 1996. View at Google Scholar
  13. K. Tanaka, Y. Adachi, S. Suzuki, K. Nishiwaki, and N. Matsuda, “ECG changes after the induction of general anesthesia with remifentanil: a report of three cases,” Masui, vol. 61, no. 10, pp. 1128–1132, 2012. View at Google Scholar
  14. E. Hamaguchi, H. Kawano, S. Kawahito, H. Kitahata, and S. Oshita, “Torsade de pointes associated with severe bradycardia after induction of general anesthesia,” Masui, vol. 60, no. 9, pp. 1097–1100, 2011. View at Google Scholar
  15. J. Mizuno, S. Kato, K. Ino, T. Yoshimura, S. Yunokawa, and S. Morita, “Intermittent bradycardia-dependent bundle branch block during sevoflurane and remifentanil anesthesia,” Masui, vol. 58, no. 8, pp. 976–979, 2009. View at Google Scholar · View at Scopus
  16. Y. Nishio, K. Hara, G. Obara, and T. Sata, “General anesthesia with remifentanil for a patient having sinoatrial block and constrictive pulmonary disorder,” Masui, vol. 57, no. 8, pp. 1002–1004, 2008. View at Google Scholar · View at Scopus
  17. K. Fujii, H. Iranami, Y. Nakamura, and Y. Hatano, “High-dose remifentanil suppresses sinoatrial conduction and sinus node automaticity in pediatric patients under propofol-based anesthesia,” Anesthesia and Analgesia, vol. 112, no. 5, pp. 1169–1173, 2011. View at Publisher · View at Google Scholar · View at Scopus